The study evaluates the efficacy of a new quadrivalent mRNA influenza vaccine, finding it to be highly immunogenic and protective in a mouse model. Compared to traditional vaccines, the mRNA-based option offers advantages like reduced production time and elimination of the risk of growth-promoting mutations.
Lab Tests That Escape FDA Oversight May Come Under Agency Review
The FDA issued its long-awaited proposal for regulating laboratory developed tests (LDTs) on Friday. The proposed rule would amend FDA regulations to make explicit that
September 30, 2023